[Atrial natriuretic polypeptide (alpha-hANP) in patients with chronic respiratory failure]. 1987

S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D012131 Respiratory Insufficiency Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed) Acute Hypercapnic Respiratory Failure,Acute Hypoxemic Respiratory Failure,Hypercapnic Acute Respiratory Failure,Hypercapnic Respiratory Failure,Hypoxemic Acute Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Depression,Respiratory Failure,Ventilatory Depression,Depressions, Ventilatory,Failure, Hypercapnic Respiratory,Failure, Hypoxemic Respiratory,Failure, Respiratory,Hypercapnic Respiratory Failures,Hypoxemic Respiratory Failures,Respiratory Failure, Hypercapnic,Respiratory Failure, Hypoxemic,Respiratory Failures
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
January 1986, Peptides,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
January 1987, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
March 1985, European journal of pharmacology,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
January 1985, Clinical and experimental hypertension. Part A, Theory and practice,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
March 1985, Life sciences,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
April 1988, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
September 1985, European journal of pharmacology,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
April 1990, Protein engineering,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
January 1984, Biochemical and biophysical research communications,
S Kubo, and S Tsuno, and Y Mine, and K Fujita, and Y Ueda, and K Kohno, and A Nakanishi, and K Hara
September 1985, Nihon Jinzo Gakkai shi,
Copied contents to your clipboard!